Leadership: Difference between revisions

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
[checked revision][checked revision]
No edit summary
No edit summary
 
Line 29: Line 29:


File:Kitahara, Sumire 2023.jpg|Sumire K. Kitahara, MD, Associate Professor, Pathology & Laboratory Medicine, Cedars-Sinai (Los Angeles); '''[mailto:Sumire.Kitahara@cshs.org <u>Sumire.Kitahara@cshs.org</u>]'''; '''Associate Editor CCGA [Mature T- and NK-cell Neoplasms Section]'''
File:Kitahara, Sumire 2023.jpg|Sumire K. Kitahara, MD, Associate Professor, Pathology & Laboratory Medicine, Cedars-Sinai (Los Angeles); '''[mailto:Sumire.Kitahara@cshs.org <u>Sumire.Kitahara@cshs.org</u>]'''; '''Associate Editor CCGA [Mature T- and NK-cell Neoplasms Section]'''
File:Professional headshot.jpg|Kathleen Schieffer,  PhD, FACMG, Clinical Laboratory Director, Institute for Genomic Medicine, Nationwide Children’s Hospital; Assistant Professor, Departments of Pathology and Pediatrics, The Ohio State University; '''[mailto:Kathleen.Schieffer@nationwidechildrens.org <u>Kathleen.Schieffer@nationwidechildrens.org</u>]'''; '''Associate Editor CCGA [Soft Tissue and Bone Tumours]'''
</gallery>
</gallery>



Latest revision as of 10:54, 22 March 2025

Meet your editors! We welcome questions and your participation in the CCGA.


Previous Associate Editors:

Snehal Patel, MD, PhD; Co-Associate Editor CCGA [Mature B-Cell Neoplasms Section], Associate Editor CCGA [Mature T- and NK-cell Neoplasms Section]

Yassmine Akkari, PhD; Associate Editor CCGA [ALL Section]